---
identifier: "/us/cfr/t21/s820.20-820.30"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 820.20-820.30 - §§ 820.20-820.30 [Reserved]"
title_number: 21
title_name: "Food and Drugs"
section_number: "820.20-820.30"
section_name: "§§ 820.20-820.30 [Reserved]"
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "H"
subchapter_name: "MEDICAL DEVICES"
part_number: "820"
part_name: "QUALITY MANAGEMENT SYSTEM REGULATION"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 351, 352, 360, 360c, 360d, 360e, 360h, 360i, 360j, 360l, 371, 374, 381, 383; 42 U.S.C. 216, 262, 263a, 264."
regulatory_source: "89 FR 7523, Feb. 2, 2024, unless otherwise noted."
cfr_part: "820"
---
- Identifier
- /us/cfr/t21/s820.20-820.30
- Currency
- 2026-04-05
- Positive Law
- No
- Updated
- 2026-04-05
- Chapter
- Food and Drug Administration, Department of Health and Human Services
- Authority
- 21 U.S.C. 351, 352, 360, 360c, 360d, 360e, 360h, 360i, 360j, 360l, 371, 374, 381, 383; 42 U.S.C. 216, 262, 263a, 264.